Nirad
Nirad Jain is a partner in Bain & Company's New York office. He co-leads Bain’s global Healthcare Private Equity and Corporate M&A practices.
Nirad has almost 20 years of management consulting experience, partnering with corporate clients and financial investors to drive results. He has led more than 200 client engagements across the healthcare value chain, including diligence, corporate M&A, transformation, performance improvement and strategy work in the services, payer, provider, medical device and pharmaceuticals sectors.
He has built significant expertise at the intersection of private equity and healthcare and is frequently cited in the media, including appearances on Bloomberg TV, The New York Times, The Wall Street Journal, Reuters, CNBC, Forbes, Buyouts and many others around the globe.
Prior to joining Bain in 2005, Nirad worked for another consulting confirm in New York, where he advised clients on growth and M&A strategies. He also previously worked in the not-for-profit sector.
Nirad holds an MBA from The Wharton School, a Master of Science from Stanford University and a Bachelor of Science, with honors, from Columbia University.
Recent Insights
- “Welcome Letter: Sizing Up the Great Adaptation,” Report, 2022년3월16일
- “Healthcare Private Equity Market 2021: The Year in Review ,” Report, 2022년3월16일
- “Covid-19 Fallout: Investing to Handle Pandemics Present and Future,” Report, 2022년3월16일
- “Now Playing: The Return of the Healthcare Megadeal,” Report, 2022년3월16일
- “Growth Equity Blossoms in Emerging Tech-Related Healthcare Firms ,” Report, 2022년3월15일
- “Healthcare Private Equity Deal Returns: Look to Revenues and Multiples,” Report, 2022년3월15일
- “Healthcare Corporate M&A: Rebounding from the Pandemic,” Report, 2022년3월15일
- “Healthcare Exits: Corporate Buyers Step Up,” Report, 2022년3월15일
- “Healthcare Private Equity in North America: Macro Trends Broaden Investment Opportunities ,” Report, 2022년3월15일
- “Biopharma: Traditional Pharma Services Lead the Way ,” Report, 2022년3월15일
In the News
- “Megadeals are here to stay, and they’re redefining the healthcare landscape,” Press release, 2022년3월15일
- “Bain Feature: Healthcare Private-Equity Scores Record Year in Asia,” The Wall Street Journal, 2021년3월22일, 헬스케어
- “Healthcare private equity buyouts posted record-setting volumes in 2020 after a year of unprecedented upheaval for global healthcare,” Press release, 2021년3월16일
- “Global healthcare private equity deals rise in 2020, total value declines,” Modern Healthcare, 2021년3월16일, 헬스케어
- “Bain Feature: Healthcare Sponsors Flocked to Public Markets in 2020,” The Wall Street Journal, 2021년3월16일, 사모펀드